ANTIMYCOBACTERIAL ACTIVITY OF METHDILAZINE (MD), AN ANTIMICROBIC PHENOTHIAZINE

被引：25
作者：
CHAKRABARTY, AN
BHATTACHARYA, CP
DASTIDAR, SG
机构：
[1] UNIV CALCUTTA,COLL MED,DEPT MED MICROBIOL & PARASITOL,CALCUTTA 700073,W BENGAL,INDIA
[2] JADAVPUR UNIV,DEPT PHARM,DIV MICROBIOL,CALCUTTA 700032,W BENGAL,INDIA
来源：
APMIS | 1993年 / 101卷 / 06期
关键词：
METHDILAZINE; ANTIMYCOBACTERIAL ACTIVITY;
D O I：
10.1111/j.1699-0463.1993.tb00133.x
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Methdilazine (Md) could inhibit various Mycobacterium spp. at 5-15 mug/ml concentrations in vitro as well as in vivo. When Md was tested in combination with streptomycin (Sm), rifampicin (Rf) or methyl-DOPA (m-D), it showed synergistic effects only with respect to methyl-DOPA.
引用
收藏
页码：449 / 454
页数：6
相关论文
共 35 条
[21]  
KRISTIANSEN JE, 1986, ACTA PATH MICRO IM B, V94, P393
[22]  
KRISTIANSEN JE, 1986, ACTA PATH MICRO IM B, V94, P103
[23]  
Krogstad D. J., 1980, ANTIBIOTICS LABORATO, P298
[24]  
MCCLATCHY JK, 1980, ANTIBIOTICS LABORATO, P135
[25]   ANTIMYCOBACTERIAL BETA-AMINOKETONES [J].
MEINDL, W ;
BOHM, M .
ARCHIV DER PHARMAZIE, 1987, 320 (06) :507-514
[26]  
MOLNAR J, 1977, ACTA MICROBIOL HUNG, V24, P1
[27]  
OBERHOFER TR, 1985, MANUAL PRACTICAL MED, P352
[28]  
PARKER MT, 1990, TOPLEY WILSONS PRINC, V2, P43
[29]   THE USE OF MICE IN EXPERIMENTAL CHEMOTHERAPY OF TUBERCULOSIS .1. RATIONALE AND REVIEW OF THE LITERATURE [J].
RALEIGH, GW ;
YOUMANS, GP .
JOURNAL OF INFECTIOUS DISEASES, 1948, 82 (03) :197-204
[30]  
RAY S, 1980, BRIT J EXP PATHOL, V61, P465
1234